Skip to main content
Edition No. 100 · GlobalEst. 2026
S&P 5007,561.67+2.51%Dow Jones52,347.55+2.07%Nasdaq25,136.27+2.27%FTSE 10010,902.56+2.14%DAX26,749.95+3.60%Nikkei 22561,142.35+4.03%Hang Seng23,637.60-3.45%EUR/USD1.1028-1.07%GBP/USD1.3212-1.11%Gold3,886.30-3.57%Crude Oil88.56+2.93%Bitcoin65,326.47-11.68%S&P 5007,561.67+2.51%Dow Jones52,347.55+2.07%Nasdaq25,136.27+2.27%FTSE 10010,902.56+2.14%DAX26,749.95+3.60%Nikkei 22561,142.35+4.03%Hang Seng23,637.60-3.45%EUR/USD1.1028-1.07%GBP/USD1.3212-1.11%Gold3,886.30-3.57%Crude Oil88.56+2.93%Bitcoin65,326.47-11.68%

New Research Links Shingles Vaccination to Reduced Dementia Risk in Older Adults

A study of health records in Wales suggests that the shingles vaccine may slow cognitive decline and lower the likelihood of developing dementia.

By Planet Earth News Health & Fitness Desk· Published 2026-11-09· 2 min read
Thirdman / Pexels / Pexels
PENN Explainer

Hear this story explained in 90 seconds.

A recent study conducted by researchers at Stanford Medicine has identified a potential link between the shingles vaccine and a lower risk of developing dementia in older adults. By analyzing health records from individuals in Wales, scientists observed that those who received the vaccine were 20 percent less likely to develop dementia over a seven-year period compared to those who did not. The findings suggest that the vaccine may play a role in protecting cognitive health as people age. This research adds to a growing body of evidence regarding how preventative measures can influence long-term brain function. The study was highlighted as a significant advancement in medical research during a year-end review of scientific achievements at Stanford. While the results are promising, experts emphasize that further investigation is necessary to fully understand the biological mechanisms at play. The researchers noted that the vaccine appeared to slow the progression of dementia in those who had already begun to show signs of cognitive decline. This discovery offers a new perspective on how common vaccinations might provide benefits beyond their primary purpose of preventing infectious diseases. The study involved a large cohort of older adults, providing a robust dataset for the researchers to examine. By comparing the health outcomes of vaccinated and unvaccinated individuals, the team was able to isolate the potential protective effects of the shingles immunization. This type of observational research is crucial for identifying patterns that can lead to more targeted public health strategies. The findings have sparked interest in the medical community regarding the potential for other vaccines to offer similar neuroprotective benefits. Future research will likely focus on replicating these results in different populations to confirm the findings. Scientists are also looking to explore whether the timing of the vaccination impacts the level of protection provided against cognitive decline. As the global population continues to age, identifying simple and accessible ways to support brain health remains a top priority for medical professionals. The researchers hope that these insights will eventually lead to updated clinical guidelines for older adults. By integrating this information into routine care, healthcare providers may be better equipped to help patients maintain their cognitive abilities for longer periods.

You've reached your free article limit

You've read 10 of 10 free articles this month. Subscribe to Planet Earth News Network for unlimited access to neutral, global journalism — plus puzzles, podcasts, and the weekly newsletter.

Already a subscriber? Sign in.

Ask the Author

Subscribers can ask the journalist a question about this story. Subscribe to ask.

Neutrality note

Auto-harvested from global news wires and presented neutrally by PENN.

Share this article

to vote

Comments

No comments yet — be the first to share your thoughts.

Related stories in Health and Fitness